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BASIC AND TRANSLATIONAL SCIENCE
Early HIV-1 Infection Is Associated With Reduced
Frequencies of Cervical Th17 Cells
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Background: The hallmark of HIV infection is progressive but
variable rates of systemic and mucosal CD4 depletion, leading to
immunodeficiency. The impact of early HIV infection on cervical
CD4+ T-cell populations in humans remains poorly described.
Methods: We analyzed cytobrush-derived immune cells by flow
cytometry and cytokines in cervicovaginal lavage from participants
in early HIV (,6 months postinfection), chronic HIV, and HIV-
uninfected controls.
Results: CD4:CD8 ratios declined rapidly in both the cervix and the
blood following HIV infection. In contrast, absolute cervical CD4+ T-cell
counts in early HIV were comparable to HIV-uninfected participants,
declining only in chronic infection. Early HIV infection was associated
with increases in RANTES and MIP3a in cervicovaginal fluids. Concur-
rently, slight increases in activated cells (CD38+HLA-DR+) and higher
levels of CTLA4 expression on Tregs in the cervix were observed.
Although study groups did not differ with respect to levels of CCR5,
integrin B7, or CD69, the frequencies of Th17 cells (defined as
CCR6+CCR102) was reduced by .10-fold in early HIV infection
and Th1 cells (defined as CCR62CXCR3+) were reduced by .2-fold.
Although CCR6+CCR102 cells did not differ in HIV receptor
expression, these cells produced higher levels of interferon gamma
and interleukin 17.
Conclusions: These data support the model of initial CD4+ T-cell
depletion followed by overall T-cell influx in response to infection and
concomitant increases in immune activation, inflammation, and regu-
latory markers. These data are among the earliest characterization of
the cellular milieu in the female genital tract following male-to-female
HIV transmission.
Key Words: HIV, early infection, CD4+ T cells, inflammation,
chemokine receptors
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INTRODUCTION
Although other immune cells can become HIV infected,
most evidence suggests that CD4+ T cells at mucosal surfaces
are the primary cellular targets of HIV1–3; therefore, their
relative frequencies at the time of exposure may function as
a determinant of HIV transmission.4 Although the differential
susceptibility of activated cells has been demonstrated,5 an
understanding of the how different T helper subsets are tar-
geted by HIV in vivo remains only partially defined.6
The immunological and functional heterogeneity of
helper T-cell subsets continues to be realized. These functions
are most often defined by combinations of cytokine pro-
duction and chemokine receptor expression that link cellular
function to location by selective homing mechanisms.7 In
addition to Th1 and Th2 cells, many new subsets continue
to be described. CD4+ T cells that secrete interleukin 17 (IL-
17) (Th17 cells) were depleted in animal models and in some
studies of HIV-infected humans, particularly from the gut.8
The nature of this loss and immune dynamics during early
HIV infection, in general, are thought to be important predic-
tors of HIV disease progression rates.
CD4+ T cells are transiently and rapidly depleted from
the gut mucosa following simian immunodeficiency virus
(SIV) and HIV infections and do not readily recover in the
absence of treatment.9 Although well established in the gut,
the kinetics of this loss from other mucosal sites is less con-
sistent. A number of groups have characterized CD4+ T-cell
loss from the female genital tract during acute SIV infection
of non-human primates. Some studies suggest genital CD4
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numbers are relatively maintained during HIV infection.10,11
Others suggest that CD4+ T cells are reduced at the endocervix
during chronic HIV infection,12–15 but the impact of early HIV
infection on mucosal CD4+ T-cell subsets have not been well
described. Understanding these could have important implica-
tions for understanding how HIV infection impacts genital
health. To address this, we characterized the CD4+ T cells
and immune milieu of the cervix in participants during the
early phase of HIV infection and compared these parameters
to chronic HIV and HIV-uninfected controls.
METHODS
Study Cohort
All participants were enrolled from female sex worker
cohorts in Nairobi. All gave informed written consent to
participate in this cross-sectional study, which was approved at
Institutional Review Boards at collaborating universities. The
study was divided into 2 parts. In part 1, T-cell populations of
participants in the early phase of HIV infection were compared
with HIV-uninfected and chronic HIV-infected antiretroviral
therapy–naive participants. Based on these initial results, we
expanded our flow cytometry panel to better understand the
types of T cells that might be altered in early HIV. In this
second part, additional early HIV-infected individuals were
compared with additional HIV-infected (untreated) and HIV-
uninfected participants. A random convenience sample was
selected for both parts based on the criteria established for
study groups (described below), and sample sizes for each part
are reported in their respective Results sections.
As a part of routine clinical care, participants received
health education and HIV/sexually transmitted infection pre-
vention and treatment as per national Kenyan guidelines. Early
HIV infection was defined as those sampled less than 6 months
since estimated time of HIV infection, calculated as the midway
point between the last negative and first positive visit. All
participants in the HIV-infected group had been HIV+ for .9
months at the time of sampling and were not yet initiated on
antiretroviral therapy. HIV-uninfected participants were selected
on the basis of a negative HIV serological test. No participants
were pregnant or menstruating at the time of sample collection.
Cervical mononuclear cells were isolated from study
participants by a combined endocervical cytobrush and ectocer-
vical spatula sample, as described.16 Cervicovaginal lavage
(CVL) samples [3 mL of phosphate-buffered saline (PBS)] were
also collected from the same visits. HIV testing was performed by
rapid test (Determine; Inverness Medical, Waltham, MA) and
confirmatory enzyme-linked immunosorbent assay (Vironostika;
Biomerieux, Craponne, France). CD8 and CD4 counts in the
blood were measured using Becton Dickinson Trucount reagents
[Becton Dickinson (BD), Franklin Lakes, NJ], and sexually trans-
mitted infection diagnostics were performed, including Chla-
mydia trachomatis (Roche Amplicor), Neisseria gonorrhoeae
(Roche Amplicor), Trichomonas vaginalis (In-Pouch Kit; Biomed
Diagnostics Inc., Singapore), rapid plasma reagin for syphilis
(Diagnostics Worldwide), and bacterial vaginosis (Gram stain
and Nugent scoring). Genital HIV viral load (VL) was measured
on a subset of early infection participants using the Roche Am-
plicor test.
Mucosal Sampling and Processing
CVL samples were taken by applying 2 mL of sterile
PBS over the ectocervix and collected using transfer pipette
from the posterior fornix. Subsequently, one endocervical
cytobrush followed by one ectocervical cell spatula and
PBS mini-lavage was collected into 10 mL of PBS. Cyto-
brushes were placed into the cervical os, rotated 360 degrees,
and placed into the tube. An Ayres spatula was gently run
over the ectocervix, with a 2-mL lavage to collect cells from
the posterior fornix.17 Specimens were combined in the same
tube and transported to the laboratory on ice within 4 hours of
collection. Cervical mononuclear cells were vortexed, filtered
through a 100-mm filter, washed once, and resuspended in
PBS-1 before staining. Cells were cryopreserved in liquid
nitrogen in media containing 10% dimethyl sulfoxide and
90% fetal bovine serum.
Flow Cytometry for Cell Surface Phenotyping
Cryopreserved cells from selected participants were
thawed and washed in warm media containing RPMI 10% fetal
bovine serum, followed by further washing in PBS-1. Cells were
then stained in 96-well V-bottom plates with a panel of surface
antibodies (to avoid cell permeabilization in cervical samples) in
various combinations. These included CD3-Alexa700, CD4-
ECD (Beckman Coulter), CD8-V450, CD69-PECy7, CCR5-
APCCy7, CXCR3-FITC, CD161-FITC, CCR10-PE (R&D
Systems), CTLA4-PE, HLA-DR-APC, CD39-APC, integrin
b7-PECy5, CCR6-PECy7, CD38-V450, and CD25-V450.
All antibodies were from unless otherwise indicated. Cells were
stained with pre-titrated amounts of antibodies and Live-Dead
Aqua (Invitrogen) for 20 minutes at room temperature, washed,
and fixed in 1% paraformaldehyde. Fixed samples were acquired
on a BD LSRII configured for 10 colors. The entire cervical
sample was acquired to estimate the total number of cells recov-
ered. Data were analyzed using FlowJo v. 8.8.6 for Mac. Gates
were set using fluorescence minus one controls.
Stimulations
We measured cytokine expression in various CD4+ T-
cell subsets, as defined by CCR6, CCR10, and CXCR3
expression. Peripheral blood mononuclear cells were stimu-
lated with phorbol 12-myristate 13-acetate (1 ng/mL) and
ionomycin (1 mg/mL) for 6 hours at 37°C, with Brefeldin A
(BD; 1 mL per mL) added for the last 5 hours. Following
stimulation, cells were washed and stained with monoclonals
for surface markers, including CD3, CD4, CCR6, CXCR3,
CCR10, and Live-dead for 30 minutes at 4°C. Cells were then
washed, permeabilized for 15 minutes using Perm/wash buffer
(BD), and stained with intracellular cytokine monoclonal anti-
bodies, including interferon gamma, IL-17a, and IL-22 for
30 minutes at 4°C. Samples were fixed with 2% paraformalde-
hyde and acquired immediately on a BD Fortessa. At least
500,000 events within the lymphocyte gate were acquired per
sample and background values were subtracted. Th17 cells were
defined as those expressing CCR6 and not CCR10, whereas
Th1 cells were those expressing CXCR3 but not CCR6, as
described elsewhere.18–20
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Quantitation of Soluble Markers
Soluble factors were quantified from CVL using the Meso
Scale Discovery electrochemiluminescent enzyme-linked immu-
nosorbent assay system and compared between participant
groups. A panel of 14 markers was assessed (GM-CSF, IL-1a,
IL-8, MCP1, MIG, MIP3a, RANTES, IL-10, IL-17, IL-1b, IL-6,
IP10, MIP1b, and TNF-a). CVL was plated at 50 mL per well
and run in duplicate. A standard curve was used to determine the
concentration (in picogram per milliliter). The lower limit of
quantitation was determined as the dilution in which the coeffi-
cient of variation exceeded 30%. Any sample above the range of
the standard curve was repeated following dilution. Samples were
run and analyzed by personnel who were blinded to study status.
Statistical Analyses
All cytokine data were log10 transformed to normalize
distributions for parametric analyses. Flow cytometry data
were analyzed using nonparametric tests. P values , 0.05
were considered statistically significant.
RESULTS
Study Participants
The first phase of the study compared cervical CD4+ T-cell
numbers and CD4:CD8 ratios between participants with early
HIV-1 infection and controls, whereas the second phase com-
pared the relative frequencies of particular CD4+ T-cell subsets
between groups. A random convenience sample was recruited for
these consecutive phases on the basis of the study group defini-
tions described in the Methods section. Selected demographic
and clinical data for all study groups are shown in Table 1.
The median estimated time from infection to sampling in the
early group was 93 days (interquartile range, 70–125 days).
Samples were only available to conduct cervical viral load anal-
yses on 7 of 11 participants in early HIV infection. VL was
detected in 4 of 7, at a median of 1422 copies per milliliter,
a detection frequency and level that is similar to that observed
in separate HIV+ chronically infected cohorts.21
Decreased CD4:CD8 Ratios Were Observed in
the Cervix During Early HIV Infection
We first compared the frequencies of T cells (part 1),
expressed as a ratio of the proportions of CD4+/CD8+CD3+
T cells, in the cervix and blood of all participants (Fig. 1A). This
comparison included participants in early HIV (n = 5), chronic
HIV (n = 17), and HIV-uninfected controls (n = 21). As
expected, CD4:CD8 ratios were dramatically decreased in the
blood and cervix of all HIV+ participants compared with match-
ing compartments of HIV-uninfected controls (Fig. 1B,
P , 0.001). A slightly lower CD4:CD8 ratio was observed in
the cervix compared to matching blood samples of HIV-
uninfected participants, although this was not statistically signif-
icant (P = 0.19). In contrast, cervical CD4:CD8 ratios were
significantly lower than that of blood for both HIV-infected
groups (early, P = 0.028; chronic, P = 0.0004). These data
suggest that naturally lower CD4:CD8 ratios are decreased even
further by HIV infection, even as early as the first few months.
Number of Cervical CD4+ T Cells Was
Decreased in Chronic but not Early
HIV Infection
In addition to the relative ratio of T-cell subsets, we
acquired the entire cytobrush sample from each participant in
a blinded fashion, allowing us to also compare the overall
number of CD4+ T cells between participant groups. For this
comparison, we included data from parts 1 and 2 (described
below), which included participants in early HIV (n = 11),
chronic HIV (n = 26), and HIV-uninfected controls (n = 132).
The numbers of cervical CD4+ T cells in early HIV infection
were comparable to HIV-uninfected women (median 1524 vs.
1852, P = 0.6, Fig. 1C). This is in contrast to women with
chronic HIV infection, who had a 0.5 log10 decrease in CD4+
cell number (median 351) compared with HIV-uninfected
(P , 0.001) and early HIV-infected women (P = 0.003).
These data suggest that although CD4:CD8 ratios decrease
rapidly following infection, CD4+ T-cell counts remain stable
in the first few months of HIV infection.
Frequencies of Chemokine Receptor–Defined
Subsets Are Decreased in Early HIV Infection
Although CD4+ T cells were not decreased in number in
early HIV infection, there could be changes in the frequencies
of various CD4 subpopulations, defined by their surface
marker expression. To this end, we extended our initial study
by enrolling additional participants to compare the relative
frequencies of CD4+ T cells expressing various combinations
















93 (70–125) 826 (261–2285) n/a
CD4 count (median,
IQR)
475 (130–478) 331 (301–590) n/a
STI at study visit
NG 0% (0/11) 12.0% (3/25) 0.8% (1/122)
CT 9.1% (1/11) 4.0% (1/25) 1.6% (2/122)
TV 0% (0/11) 4.0% (1/25) 3.3% (4/122)
BV
Intermediate 18.1% (2/11) 0% (0/13) 9.5% (2/21)
BV 18.1% (2/11) 69.0% (9/13) 52.3% (11/21)




45.5% (5/11) 27.8% (5/18) 39% (7/19)
*Definition of study groups: (1) HIV uninfected by serologic testing at the time of
the study, (2) HIV-infected participants who were recently diagnosed (“HIV+ Early”),
(3) HIV-infected participants not in early infection and ART naive.
BV, bacterial vaginosis; CT, Chlamydia trachomatis; IQR, interquartile range; n/a,
not applicable for this study group; NG, Neisseria gonorrhoeae; RPR, rapid plasma
reagin; STI, sexually transmitted infection; TV, Trichomonas vaginalis.
McKinnon et al J Acquir Immune Defic Syndr  Volume 68, Number 1, January 1, 2015
8 | www.jaids.com  2014 Lippincott Williams & Wilkins
of chemokine receptors, activation markers, and HIV co-
receptors. This comparison included participants in early HIV
(n = 6), chronic HIV (n = 9), and HIV-uninfected controls
(n = 113). Th17 cells, defined here as CCR6+CCR102CD4+
T cells, were depleted by 10- to 15-fold in early HIV infection
compared with uninfected and chronically infected participants
(median 1.6% vs 24.6% and 32.0%, P , 0.001 and 0.0004;
Fig. 2A). A more modest 2-fold reduction in Th1 cell frequency
(defined as CCR62CXCR3+) was observed in the same groups
(median 8.9 vs. 16.9 and 16.7, P = 0.026 and 0.018). No changes
in overall levels of CCR5, integrin beta7, or CD69 were observed,
although a slight decrease in CD69 mean fluorescence intensity
was observed in early HIV (P = 0.032; see Figure S1, Supple-
mental Digital Content, http://links.lww.com/QAI/A583). These
data suggest that in first months of HIV infection, certain cervical
T-cell populations are decreased compared with HIV chronic and
uninfected controls.
Soluble Inflammatory Markers Are Increased
in Cervicovaginal Fluid During Early
HIV Infection
Previous studies suggest that acute HIV infection is
associated with genital tract inflammation.22 We next assessed
levels of inflammatory cytokines in the genital tract from the
participants in part 2 of the study using a multiplex panel of
14 cytokines. Ten of 14 markers were detected in .90% of
participants and analyzed as continuous variables. Early HIV
was associated with significant increases for both RANTES
and MIP3a, the ligands of CCR5 and CCR6, respectively
(Fig. 2B). The median levels of RANTES were 17.6, 3.1,
and 3.5 pg/mL in the early, chronic, and uninfected groups,
respectively (P , 0.0001 and P = 0.003 for early vs. unin-
fected and early vs. chronic, respectively); corresponding val-
ues for MIP3a were 543.4, 146.4, and 134.3 pg/mL (P =
0.016 and 0.07). Slight increases in CXCR3 ligands IP10
and MIG were also observed, although these were not statis-
tically significant (P . 0.1, data not shown). This confirms
that early HIV infection is associated with acute mucosal
inflammation, which may have implications for the immune
cell frequencies measured at this time.
Expression of Regulatory and Activation
Markers is Slightly Increased in Early
HIV Infection
We also compared frequencies of mucosal regulatory
T cells between participant groups, using CD25, CD39, and
CTLA-4 expression (Fig. 3). FoxP3 was omitted to avoid cell
loss because of permeabilization. Although CD25+CD39+CD4+
FIGURE 1. Reduced CD4:CD8 ratios
but not frequencies in early HIV
infection are accompanied by
increased levels of genital tract che-
mokines. A, Representative flow cy-
tometry plots for blood and cervical
T-cell staining in the 3 participant
groups. All plots were gated on live
singlets and CD3+ cells. B, CD4:CD8
ratios are compared in the periph-
eral blood (P, closed squares) and
the cervix (C, open squares) in
matched participants for each study
group. P values for the HIV2 vs. HIV+
comparisons were all significant but
not shown on the graph (see text for
details). C, The numbers of cervical
CD4+ T cells/cytobrush are compared
between early, chronic, and unin-
fected participants.
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T-cell (Treg) frequencies did not differ between HIV early and
uninfected participant groups (median 47.4% vs. 35.9%, P =
0.27), Tregs were increased in chronic HIV infection (median
54.4%) compared with the uninfected group (P = 0.0083).
Tregs constitutively express CTLA-4, and CTLA-4 expres-
sion on CD39+CD25+ Tregs was further increased in early
HIV infection compared with either control group (early,
96.2% vs. chronic, 89.2%, P = 0.036; and uninfected,
86.8%, P = 0.002). In addition to Tregs, we also compared
levels of chronic immune activation markers in early HIV
infection at the cervix, based on CD38 and HLA-DR expres-
sion. In contrast to the early activation marker CD69, there
was a trend to increased levels of CD38+HLA-DR+CD4+
T cells in the early versus chronic and uninfected groups
FIGURE 3. Frequency of regulatory
T cells and CTLA4 expression in early
HIV infection. CD25+CD39+ Tregs
(left), CTLA4+ CD25+CD39+ Tregs
(middle), and CD38+HLA-DR+ (right)
CD4+ T cells are compared between
groups. Red bars indicate medians.
P values were calculated using the
Mann–Whitney test.
FIGURE 2. Depletion of
CCR6+CCR102CD4+ T cells during
early HIV infection. A, Frequencies
of CCR6+CCR102CD4+ and
CCR62CXCR3+CD4+ T cells in each
study group. B, Concentrations of
RANTES and MIP3a in each study
group.
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(35.6% vs. 18.2% and 19.8%, P = 0.1 and 0.06, respectively).
These data suggest that early HIV is a dynamic time for
cervical T-cell populations, with several subsets increasing
or decreasing in their relative frequencies.
HIV Receptor Expression and Cytokine
Production by Depleted Cervical Subsets
To determine potential reasons that could explain cervical
Th17 depletion, we compared levels of HIV co-receptors and
cytokine expression on various T helper subsets. There was no
preferential CCR5 expression on CCR6+CCR102CD4+ T cells;
in fact, it was the CCR6+CCR10+ subset that had the highest
CCR5 expression (P , 0.001; Fig. 4A). Similar data were
obtained for integrin beta7 (data not shown). In terms of cyto-
kine production, technical limitations precluded reliable data on
cytokine production from chemokine receptor subsets in cervi-
cal T cells. However, in the peripheral blood of 5 healthy
donors, CCR6+CCR102CD4+ T cells expressed significantly
higher levels of both IL-17 and interferon gamma (analysis of
variance, P = 0.014; Fig. 4B). These data confirm that this
chemokine receptor–defined subset is enriched for Th17 (and
possibly Th1) cells, in line with previous observations.18–20
DISCUSSION
These data build on previous studies that reported CD4+
T-cell depletion in the cervix in chronic HIV infection and
acute CD4 depletion in non-human primate–SIV models, with
implications for the potential kinetics and immunological
details of this depletion. Broadly, the number of cervical
CD4+ T cells did not differ between early HIV and HIV-
uninfected participants, but the CD4:CD8 ratio declined
rapidly following HIV infection (earlier than the blood).
The effect of early HIV on the CD4:CD8 ratio but not overall
CD4 number is likely explained by an influx of T cells in
general—and particularly those expressing CD8—during this
phase of HIV infection. Mucosal inflammation is prominent
during this early phase, and therefore, a combination between
immune cell influx and loss is a logical response to infection.
The finding of proportionally fewer mucosal CD4 cells, even
in the absence of HIV infection, is physiologically consistent
with CD8+ T cells having a higher tendency toward effector
function and their emerging roles as tissue resident memory
cells.7 HIV infection seems to exacerbate this difference, and
at a very early stage posttransmission, resulting in apparently
stable cervical CD4 numbers that is likely a combination of
CD4 depletion and general T-cell influx.
Our study is also the first to analyze cervical CD4
subsets in the context of early HIV and found that Th17 cells
were almost completely depleted at this stage of infection.
Several lines of evidence suggest that HIV might preferen-
tially target Th17 cells, and we have shown that these cells
are dramatically reduced from the cervix in chronic HIV
infection.16 These data point to the importance of studying
the effect of HIV on T-cell subsets not just overall numbers.
In addition, Th17 cells are the most relevant with respect to
defense against mucosal co-infections and their loss could
possibly contribute to HIV shedding, inflammation, and
onward HIV transmission during early HIV. It is important
to note that in the current study we defined Th17 cells by
chemokine receptor expression, as opposed to cytokine
secretion in our previous study. It could be that the
CCR6+CCR102cells we measure in chronic HIV are not
able to make IL-17 because of a functional impairment.
Questions around whether the cervical tissue represents
an independent HIV reservoir or mere reflection of the
systemic compartment have been raised. Phylogenetic differ-
ences between compartments support the argument for some
degree of compartmentalization.23 Here we find increases in
CCR5 and CCR6 ligands concomitant with depletion of a key
CCR6+CD4+ T-cell subset, raising the possibility that one
effect of infection is mucosal recruitment of HIV target cells
that supports further replication. However, there was no obvi-
ous increase in HIV shedding in early HIV participants for
whom we had VL data. Resolution of this issue should have
important implications for the impact of HIV infection on
mucosal immunity at the site of exposure for women.
Limitations of our study include sampling a limited
number of participants in early HIV infection, whether the
timing was early enough to reflect events relevant to trans-
mission, and low cell recovery from the cervix, precluding
in-depth immunological characterization (including reliance
on chemokine receptor–defined subsets). Although the latter
is difficult to avoid in humans studied ex vivo, the others are
important caveats. It is technically challenging to identify
participants very early following transmission, but more
studies along these lines should be attempted. Although the
FIGURE 4. A, Mean fluorescence intensity (MFI) of CCR5
expression on 3 cervical CD4+ T-cell subsets defined by CCR6
and CCR10 expression. B, Cytokine expression (IFN-g, IL-17a,
and IL-22) in CCR6-defined and CCR10-defined subsets in
peripheral blood CD4+ T cells.
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timing of the current sampling does not allow direct compar-
ison to corresponding non-human primate studies,24 which
can sample at the earliest time points a few days postinfec-
tion, this remains the earliest characterization in humans to
date. Although our sample sizes were too small to detect
small differences, the associations we present are statistically
strong despite the small sample and may represent the most
dramatic differences present at this important, dynamic stage
of HIV pathogenesis.
In summary, our data suggest that early HIV infection
has a profound impact on the frequency and balance of
cervical CD4+ T-cell populations. A better understanding of
the earliest events following HIV acquisition in humans could
provide insight into HIV pathogenesis and the design of better
prevention and treatment strategies.
ACKNOWLEDGMENTS
The authors would like to acknowledge the support of
the Kenya AIDS Control Project and University of Toronto
teams. In particular, the authors would like to thank Joshua
Parmeres, Solomon Kamuti, Naomi Ireri, Jane Kamene, and
Jane Njoki for clinical support, and Tabitha Wanjiru for help
with data entry. The authors also thank the participants for
volunteering for these studies.
REFERENCES
1. Hladik F, Sakchalathorn P, Ballweber L, et al. Initial events in establishing
vaginal entry and infection by human immunodeficiency virus type-1.
Immunity. 2007;26:257–270.
2. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts.
Nat Rev Immunol. 2005;5:783–792.
3. Carias AM, McCoombe S, McRaven M, et al. Defining the interaction of
HIV-1 with the mucosal barriers of the female reproductive tract. J Virol.
2013;87:11388–11400.
4. McKinnon LR, Kaul R. Quality and quantity: mucosal CD4+ T cells and
HIV susceptibility. Curr Opin HIV AIDS. 2012;7:195–202.
5. Zhang Z-Q, Wietgrefe SW, Li Q, et al. Roles of substrate availability and
infection of resting and activated CD4+ T cells in transmission and acute
simian immunodeficiency virus infection. Proc Natl Acad Sci U S A.
2004;101:5640–5645.
6. Gosselin A, Monteiro P, Chomont N, et al. Peripheral blood CCR4
+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to
HIV-1 infection. J Immunol. 2010;184:1604–1616.
7. Masopust D, Schenkel JM. The integration of T cell migration, differen-
tiation and function. Nat Rev Immunol. 2013;13:309–320.
8. Brenchley JM, Douek DC. HIV infection and the gastrointestinal
immune system. Mucosal Immunol. 2008;1:23–30.
9. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion
during all stages of HIV disease occurs predominantly in the gastroin-
testinal tract. J Exp Med. 2004;200:749–759.
10. Hirbod T, Kimani J, Tjernlund A, et al. Stable CD4 expression and local
immune activation in the ectocervical mucosa of HIV-infected women.
J Immunol. 2013;191:3948–3954.
11. Prodger JL, Hirbod T, Gray R, et al. HIV infection in uncircumcised men
is associated with altered CD8 T cell function but normal CD4 T cell
numbers in the foreskin. J Infect Dis. 2013. doi: 10.1093/infdis/jit644.
12. Olaitan A, Johnson MA, MacLean A, et al. The distribution of immu-
nocompetent cells in the genital tract of HIV-positive women. AIDS.
1996;10:759–764. Available at: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/
elink.fcgi?dbfrom=pubmed&id=8805867&retmode=ref&cmd=prlinks.
Accessed February 12, 2014.
13. Quayle AJ, Kourtis AP, Cu-Uvin S, et al. T-lymphocyte profile and total
and virus-specific immunoglobulin concentrations in the cervix of HIV-
1-infected women. J Acquir Immune Defic Syndr. 2007;44:292–298.
14. Nkwanyana NN, Gumbi PP, Roberts L, et al. Impact of human immuno-
deficiency virus 1 infection and inflammation on the composition and yield
of cervical mononuclear cells in the female genital tract. Immunology.
2009;128(suppl 1):e746–e757.
15. Jaspan HB, Liebenberg L, Hanekom W, et al. Immune activation in the
female genital tract during HIV infection predicts mucosal CD4 depletion
and HIV shedding. J Infect Dis. 2011;204:1550–1556.
16. McKinnon LR, Nyanga B, Chege D, et al. Characterization of a human
cervical CD4+ T cell subset coexpressing multiple markers of HIV
susceptibility. J Immunol. 2011;187:6032–6042.
17. Iqbal SM, Ball TB, Kimani J, et al. Elevated T cell counts and RANTES
expression in the genital mucosa of HIV-1-resistant Kenyan commercial
sex workers. J Infect Dis. 2005;192:728–738.
18. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional
features of human Th17 cells. J Exp Med. 2007;204:1849–1861.
19. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and
antigenic specificity of human interleukin 17-producing T helper memory
cells. Nat Immunol. 2007;8:639–646.
20. Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but
not interleukin 17 by a subset of human skin-homing memory T cells.
Nature. 2009. Available at: http://www.nature.com/ni/journal/v10/n8/
abs/ni.1767.html. Accessed February 12, 2014.
21. Rebbapragada A, Wachihi C, Pettengell C, et al. Negative mucosal
synergy between herpes simplex type 2 and HIV in the female genital
tract. AIDS. 2007;21:589–598.
22. Roberts L, Passmore J-AS, Mlisana K, et al. Genital tract inflammation
during early HIV-1 infection predicts higher plasma viral load set point in
women. J Infect Dis. 2012;205:194–203.
23. Kemal KS, Foley B, Burger H, et al. HIV-1 in genital tract and plasma of
women: compartmentalization of viral sequences, coreceptor usage, and
glycosylation. Proc Natl Acad Sci U S A. 2003;100:12972–12977.
24. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents
mucosal SIV transmission. Nature. 2009;458:1034–1038.
McKinnon et al J Acquir Immune Defic Syndr  Volume 68, Number 1, January 1, 2015
12 | www.jaids.com  2014 Lippincott Williams & Wilkins
